Todd Foley, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 1,000,000 shares at $25.10 ($25.1M) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Open-market sale of $25.1M RYTM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |